期刊文献+

微小病变型肾病患者血尿可溶性白介素2受体的测定及其意义

THE DETERMINATION AND SIGNIFICANCE OF SOLUBLE INTERLEUKIN-2 RECEPTORS IN PLASMA AND URINE OF PATIENTS WITH MINIMAL CHANGE NEPHROTIC SYNDROME
下载PDF
导出
摘要 目的 :观察可溶性白细胞介素 2受体 ( s IL- 2 R)在微小病变型肾病综合征 ( MCNS)病人血浆和尿液中浓度变化 ,探讨其在免疫学发病机制中的意义。方法 :用 ELISA分析法检测 2 3例微小病变型肾病综合征患者发病及缓解期血、尿白介素 2受体 ,同时用 3 H- Td R掺入法检测患者淋巴细胞增殖情况。结果 :MC-NS患者在发病期血、尿 s IL- 2 Rα明显增高 ,于缓解期恢复正常。与对照组相比 ,发病期间患者尿液中增高的白介素 2受体与血清浓度不成比例地异常增高。同时尚发现血清可溶性白介素 2受体与 T细胞体外对 PHA的增殖反应呈负相关 ,缓解期恢复正常。结论 :可溶性白介素 2受体可能为血清中抑制 T细胞克隆扩增的一种因子。 Objective:To observe the change of soluble interleukin 2 receptors in plasma and urine of patients with minimal change nephrotic syndrome(MCNS) and to explore their significance in the pathogenesis of MCNS and abnormal immunity.Methods:Plasma and urine concentrations of sIL 2Rα were measured by ELISA in 23 MCNS patients and lymphocytic proliferation with PHA by 3H TdR incoporation assay.Results:The plasma and urine sIL 2R concentration in patitents with MCNS increased and the lymphocytes were in an activated sate in which they secreted some lymphokines.Conclusion:sIL 2R exerted a down modulation on the IL 2 dependent proliferative response.
出处 《滨州医学院学报》 2003年第4期241-242,共2页 Journal of Binzhou Medical University
关键词 微小病变型肾病综合征 可溶性白介素2受体 免疫学发病机制 minimal change nephrotic syndrome (MCNS) soluble interleukin 2 receptors (sIL 2R) immunity pathogenesis
  • 相关文献

参考文献9

  • 1Rubin LA. The released interleukin 2 receptor binds interleukin 2 efficiently[J]. J Immunol, 1986,137: 3841.
  • 2Pizzolo G. Soluble interleukin 2 receptors in the serum of patients with Hodgkinr s disease[J]. Br J Canc, 1987,55 : 427.
  • 3Hinoshita F. Decreased production and responsiveness of interleukin 2 in lymphocytes of patients with nephrotic syndrome[J].Nephron, 1990,55 : 427.
  • 4Maruyama K. Inhibition of vascular permeability factor production by ciclosporin in minimal change nephrotic syndrome[J].Nephron, 1992,62 : 27.
  • 5Taubo D. Pathogenesis of minimal change nehropathy. In:Gamarou JS,Glassock RJ (eds). The nephrotic syndrome[M].1988: 193.
  • 6Zuccbelli P. In Bertani T(eds), Glomerular injury 300 Years after morgagni wichting Editore. 1983,119.
  • 7Mandreoli M. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropaty[J]. Clin Nephrol. 1992,37(4):177.
  • 8Gillis S. Cell growth factor:Parameters of production and a quantitative microassay for activity[J]. J Immunol, 1978,120:2027.
  • 9Manoussakis MN. Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune disease[J]. Clin Immunol Immunopathol, 1989,50: 321.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部